| Note |
… Management of Epilepsy is a rapidly changing field… we are only just beginning to realize that both efficacy and toxicity of antiepileptic drugs is syndrome dependent. A drug may be efficacious and well tolerated in one epileptic syndrome, but ineffective or even harmful, exacerbating seizures, in another… Many clinicians are reluctant to prescribe new drugs because they fear the occurrence of rare adverse reactions. New Lamitor DT Lamotrigine 5/25mg Dispersible Tablets. A promise of brighter future. Broad-spectrum antiepileptic: Remarkably effective in generalized epilepsy, including typical and atypical absences. Drug of first choice in Lennox-Gastaut syndrome. Favourable pharmacokinetic profile: Exhibits linear pharmacokinetic features over the dose range 50-400mg. Promising new antiepileptic drug for paediatric use. Additional benefits with Sodium Valproate: Favourable response in: absence seizure, myoclonic seizures, infantile spasms. Improves quality of life: increase alterness & responsiveness. Greater awareness of surroundings. Improves cognition: improves state-dependent cognitive impairment. Also available Lamitor 50/100mg tablets. |
